Literature DB >> 18040903

[Diagnostic accuracy of the Phototest for cognitive impairment and dementia].

C Carnero Pardo1, C Sáez-Zea, L Montiel Navarro, P Del Sazo, I Feria Vilar, M J Pérez Navarro, J Ruiz Jiménez, R Vilchez Carrillo, M T Montoro Ríos.   

Abstract

INTRODUCTION: The recently developed Phototest is a simple, easy and very brief (<3 minutes) test with theoretical advantages over available dementia screening tests. Our objective was to evaluate its diagnostic accuracy under routine clinical conditions.
MATERIAL AND METHODS: A phase II cross-sectional validation study of diagnostic tests was performed in a sample of 308 patients referred to a general neurology department and in a group of 70 healthy individuals. The diagnostic accuracy (DA) of the Phototest was assessed and compared with that of the Eurotest and a verbal fluency test (VFT) in relation to the clinical diagnosis of dementia (DEM) and cognitive impairment (CI) by calculating the area under the ROC curve (aROC) and determining Sensitivity (Se), Specificity (Sp) and likelihood ratios.
RESULTS: The total sample comprised 225 subjects without CI (NOR), 58 with CI and without DEM and 95 with DEM. Phototest results showed a normal distribution in NOR subjects (33.4 +/- 3.9 [mean +/- standard desviation]) and were not influenced by educational variables. The DA of the Phototest for DEM and CI (0.95 +/- 0.01 [aRO C+/- Se]) was similar to that of the Eurotest and higher for both tests than that of the VFT. The cutoff points of 25/26 for DEM (Se=0.88 [0.80-0.94], Sp=0.90 [0.86- 0.93]) and 28/29 for CI (Se=0.90 [0.84-0.94], Sp=0.90 [0.83-0.93]) maximised the sum of Se and Sp.
CONCLUSIONS: The Phototest is a very short test of easy application that is applicable to illiterate subjects, uninfluenced by educational variables and useful to identify CI and DEM in routine clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 18040903

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  11 in total

1.  Prevalence of Drug-Induced Xerostomia in Older Adults with Cognitive Impairment or Dementia: An Observational Study.

Authors:  José Antonio Gil-Montoya; Rocío Barrios; Inés Sánchez-Lara; Cristobal Carnero-Pardo; Francisco Fornieles-Rubio; Juan Montes; Miguel Angel Gonzalez-Moles; Manuel Bravo
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

2.  Assessing the diagnostic accuracy (DA) of the Spanish version of the informant-based AD8 questionnaire.

Authors:  C Carnero Pardo; R de la Vega Cotarelo; S López Alcalde; C Martos Aparicio; R Vílchez Carrillo; E Mora Gavilán; J E Galvin
Journal:  Neurologia       Date:  2012-05-30       Impact factor: 3.109

3.  Effectiveness and costs of phototest in dementia and cognitive impairment screening.

Authors:  Cristobal Carnero-Pardo; Beatriz Espejo-Martinez; Samuel Lopez-Alcalde; Maria Espinosa-Garcia; Carmen Saez-Zea; Rosa Vilchez-Carrillo; Elisa Hernandez-Torres; Jose L Navarro-Espigares
Journal:  BMC Neurol       Date:  2011-07-29       Impact factor: 2.474

4.  Diagnostic accuracy, effectiveness and cost for cognitive impairment and dementia screening of three short cognitive tests applicable to illiterates.

Authors:  Cristóbal Carnero-Pardo; Beatriz Espejo-Martínez; Samuel López-Alcalde; María Espinosa-García; Carmen Sáez-Zea; Elisa Hernández-Torres; José Luis Navarro-Espigares; Rosa Vílchez-Carrillo
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

5.  A systematic review and meta-analysis of the diagnostic accuracy of the Phototest for cognitive impairment and dementia.

Authors:  Cristóbal Carnero-Pardo; Samuel Lopez-Alcalde; Ricardo Francisco Allegri; María Julieta Russo
Journal:  Dement Neuropsychol       Date:  2014 Apr-Jun

6.  Discriminative validity of an abbreviated Semantic Verbal Fluency Test.

Authors:  José David Herrera-García; Iago Rego-García; Virginia Guillén-Martínez; María Carrasco-García; Carmen Valderrama-Martín; Rosa Vílchez-Carrillo; Samuel López-Alcalde; Cristóbal Carnero-Pardo
Journal:  Dement Neuropsychol       Date:  2019 Apr-Jun

7.  Impact of amyloid-PET in daily clinical management of patients with cognitive impairment fulfilling appropriate use criteria.

Authors:  Eva María Triviño-Ibáñez; Raquel Sánchez-Vañó; Pablo Sopena-Novales; Juan Carlos Romero-Fábrega; Antonio Rodríguez-Fernández; Cristóbal Carnero Pardo; María Dolores Martínez Lozano; Manuel Gómez-Río
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  Reliability and Feasibility of the Memory Associative Test TMA-93.

Authors:  Emilio Franco-Macías; Silvia Rodrigo-Herrero; Andrea Luque-Tirado; Carlota Méndez-Barrio; Manuel Medina-Rodriguez; Eugenia Graciani-Cantisán; María Bernal Sánchez-Arjona; Didier Maillet
Journal:  J Alzheimers Dis Rep       Date:  2020-10-24

9.  "Don't know" sign: description and evaluation of its diagnostic accuracy for cognitive impairment.

Authors:  Iago Rego-García; José Antonio Medina Gámez; Carmen Valderrama-Martín; Virginia Guillén Martínez; Rosa Vílchez Carrillo; Cristóbal Carnero-Pardo
Journal:  Neurol Sci       Date:  2021-07-21       Impact factor: 3.307

10.  Using CT Data to Improve the Quantitative Analysis of 18F-FBB PET Neuroimages.

Authors:  Fermín Segovia; Raquel Sánchez-Vañó; Juan M Górriz; Javier Ramírez; Pablo Sopena-Novales; Nathalie Testart Dardel; Antonio Rodríguez-Fernández; Manuel Gómez-Río
Journal:  Front Aging Neurosci       Date:  2018-06-07       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.